Literature DB >> 8457200

Expression, purification and characterization of B72.3 Fv fragments.

D J King1, O D Byron, A Mountain, N Weir, A Harvey, A D Lawson, K A Proudfoot, D Baldock, S E Harding, G T Yarranton.   

Abstract

The Fv fragment of the antibody B72.3 has been produced by expression in both a mammalian and microbial system, namely Chinese hamster ovary (CHO) cells and Escherichia coli. In both cases secretion of the Fv into the culture medium was achieved, with equivalent amounts of Vh and Vl produced. The yield of Fv from CHO cells was 4 mg/l in roller-bottle culture. E. coli proved to be a more productive system with yields of 40 mg/l in shake flasks rising to 450 mg/l in fermentations. B72.3 Fv from both sources was capable of binding to antigen with similar binding ability to the Fab' fragment. A detailed sedimentation analysis, both by velocity and equilibrium techniques, revealed that the two domains of Fv are associated at high concentrations at pH values close to neutral, but dissociate at concentrations lower than approx. 0.5 mg/ml. Individual Vh or Vl polypeptides are not able to bind to the antigen and thus these results suggest that the antigen promotes assembly of Fv at the low concentrations used in the antigen-binding assays. At a pH value of 1.9, Vh and Vl are completely dissociated even at very high concentrations and are apparently unfolded at low solute concentrations. Small-angle X-ray scattering was used to measure a radius of gyration of 1.75 +/- 0.2 nm (17.5 +/- 2 A) for Fv.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457200      PMCID: PMC1132340          DOI: 10.1042/bj2900723

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  Small rearrangements in structures of Fv and Fab fragments of antibody D1.3 on antigen binding.

Authors:  T N Bhat; G A Bentley; T O Fischmann; G Boulot; R J Poljak
Journal:  Nature       Date:  1990-10-04       Impact factor: 49.962

2.  Use of 2D NMR, protein engineering, and molecular modeling to study the hapten-binding site of an antibody Fv fragment against 2-phenyloxazolone.

Authors:  S McManus; L Riechmann
Journal:  Biochemistry       Date:  1991-06-18       Impact factor: 3.162

3.  Crystallization and preliminary X-ray diffraction study of a chimaeric Fab' fragment of antibody binding tumour cells.

Authors:  R L Brady; R E Hubbard; D J King; D C Low; S M Roberts; R J Todd
Journal:  J Mol Biol       Date:  1991-06-20       Impact factor: 5.469

4.  Crystallization and preliminary X-ray diffraction study of the bacterially expressed Fv from the monoclonal anti-lysozyme antibody D1.3 and of its complex with the antigen, lysozyme.

Authors:  G Boulot; J L Eiselé; G A Bentley; T N Bhat; E S Ward; G Winter; R J Poljak
Journal:  J Mol Biol       Date:  1990-06-20       Impact factor: 5.469

5.  Crystallization and preliminary X-ray studies of the VL domain of the antibody McPC603 produced in Escherichia coli.

Authors:  R Glockshuber; B Steipe; R Huber; A Plückthun
Journal:  J Mol Biol       Date:  1990-06-20       Impact factor: 5.469

6.  Multinuclear NMR study of the structure of the Fv fragment of anti-dansyl mouse IgG2a antibody.

Authors:  H Takahashi; A Odaka; S Kawaminami; C Matsunaga; K Kato; I Shimada; Y Arata
Journal:  Biochemistry       Date:  1991-07-02       Impact factor: 3.162

7.  Site-specific attachment to recombinant antibodies via introduced surface cysteine residues.

Authors:  A Lyons; D J King; R J Owens; G T Yarranton; A Millican; N R Whittle; J R Adair
Journal:  Protein Eng       Date:  1990-08

8.  Expression of mouse immunoglobulin light and heavy chain variable regions in Escherichia coli and reconstitution of antigen-binding activity.

Authors:  H Field; G T Yarranton; A R Rees
Journal:  Protein Eng       Date:  1990-07

9.  Preparation of the Fv fragment from a short-chain mouse IgG2a anti-dansyl monoclonal antibody and use of selectively deuterated Fv analogues for two-dimensional 1H NMR analyses of the antigen-antibody interactions.

Authors:  H Takahashi; T Igarashi; I Shimada; Y Arata
Journal:  Biochemistry       Date:  1991-03-19       Impact factor: 3.162

10.  High level expression of tissue inhibitor of metalloproteinases in Chinese hamster ovary cells using glutamine synthetase gene amplification.

Authors:  M I Cockett; C R Bebbington; G T Yarranton
Journal:  Biotechnology (N Y)       Date:  1990-07
View more
  8 in total

Review 1.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

Review 2.  Monoclonal antibody form and function: manufacturing the right antibodies for treating drug abuse.

Authors:  Eric Peterson; S Michael Owens; Ralph L Henry
Journal:  AAPS J       Date:  2006-05-26       Impact factor: 4.009

3.  Linker engineering in anti-TAG-72 antibody fragments optimizes biophysical properties, serum half-life, and high-specificity tumor imaging.

Authors:  Nicholas E Long; Brandon J Sullivan; Haiming Ding; Stephanie Doll; Michael A Ryan; Charles L Hitchcock; Edward W Martin; Krishan Kumar; Michael F Tweedle; Thomas J Magliery
Journal:  J Biol Chem       Date:  2018-04-18       Impact factor: 5.157

4.  A secretory system for bacterial production of high-profile protein targets.

Authors:  Alexander Kotzsch; Erik Vernet; Martin Hammarström; Jens Berthelsen; Johan Weigelt; Susanne Gräslund; Michael Sundström
Journal:  Protein Sci       Date:  2011-03       Impact factor: 6.725

5.  One hundred seventy-fold increase in excretion of an FV fragment-tumor necrosis factor alpha fusion protein (sFV/TNF-alpha) from Escherichia coli caused by the synergistic effects of glycine and triton X-100.

Authors:  J Yang; T Moyana; S MacKenzie; Q Xia; J Xiang
Journal:  Appl Environ Microbiol       Date:  1998-08       Impact factor: 4.792

6.  Advances in animal cell recombinant protein production: GS-NS0 expression system.

Authors:  L M Barnes; C M Bentley; A J Dickson
Journal:  Cytotechnology       Date:  2000-02       Impact factor: 2.058

7.  The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi.

Authors:  Vivi Joosten; Christien Lokman; Cees AMJJ Van Den Hondel; Peter J Punt
Journal:  Microb Cell Fact       Date:  2003-01-30       Impact factor: 5.328

8.  Expression of recombinant antibodies.

Authors:  André Frenzel; Michael Hust; Thomas Schirrmann
Journal:  Front Immunol       Date:  2013-07-29       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.